A phase 2 study randomized participants to bremelanotide 1.25 mg daily and tirzepatide 2.5 mg weekly, bremelanotide alone, tirzepatide alone, and placebo, all for 4 weeks, after a 4-week run in period with tirzepatide 2.5 mg weekly (128)
Optimal timing enhances effectiveness while poor timing can waste a significant portion of each dose
Systemic recovery and general tissue repair Patients without a specific acute injury but seeking general recovery optimization or connective tissue support work with their APRN to determine the appropriate dose and route at intake
Low Starting Dose Dose per injection: about 800 mcg total blend 3 units (0.03 mL) on a U-100 insulin syringe That draw contains: GHK-Cu 500 mcg + TB-500 100 mcg + BPC-157 100 mcg + KPV 100 mcg Frequency: once daily, subcutaneous Cycle length: 48 weeks, then 24 weeks off Adjust based on how each peptide responds in the model
Each unit represents 0.01mL
Additionally, a healthy and balanced diet will also contribute to healthy skin